Infectious disease outbreaks, such as measles, HIV, and mpox, expose critical vulnerabilities across public health systems.

Adults aged 18 to 64 years with high-risk conditions demonstrate higher rates of RSV-related LRTD than those without these conditions.

Infectious Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...

A study of insured US patients shows that oseltamivir is the primary influenza antiviral, while inpatient use of peramivir continues to grow.

The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.

Live attenuated measles-mumps-rubella and varicella vaccines are not associated with an increased risk for multiple sclerosis disease relapse.

Implementation of a rapid molecular pneumonia panel is associated with earlier antimicrobial optimization among critically ill patients with pneumonia.

A meta-analysis indicates HD-IIV is superior to SD-IIV for reducing hospitalizations in adults aged 65 years and older.

For patients with axial spondyloarthritis, bimekizumab, a dual interleukin (IL)-17A and IL-17F inhibitor, is well tolerated over 3 years.